CBD Producer Brains Bioceutical Raises $31.9M Via Investment Round Led By DSM Venturing
Del Morgan & Co. acted as Brains’ financial agent for the transaction
CBD producer Brains Bioceutical Corp. has raised $31.9 million through an investment round.
DSM Venturing, the corporate venture arm of Royal DSM, a company focused on health, nutrition, and sustainable living, was a lead investor.
Del Morgan & Co. acted as Brains’ financial agent for the transaction.
Rick Brar, CEO and chairman of the Vancouver, British Columbia-based company, called the capital raise an “exciting milestone” for the company’s team.
“The growing demand for isolated CBD Active Pharmaceutical Ingredients (APIs) within the pharmaceutical and nutraceutical industry continues to expand,” Brar said. “Our team has worked tirelessly to position Brains as the market leader within the CBD industry.”
To Read The Rest Of This Article On Benzinga, Click Here
